Latest Licensing News

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

EverGreen Lithium Limited has acquired the Leonora Goldfields Project, adding a JORC-compliant inferred gold resource of 63,000 ounces and setting the stage for a targeted drilling campaign to expand and upgrade this resource.

Titanium Sands Limited has secured retention licenses for four critical exploration areas and is progressing its Environmental Impact Assessment in Sri Lanka, while engaging government officials and local landowners to navigate regulatory hurdles.

Lotus Resources is on track to restart uranium production at its Kayelekera project in Malawi by Q3 2025, backed by binding offtake contracts covering nearly 4 million pounds of uranium and a robust cash position.

Evion Group’s Maniry Graphite Project in Madagascar has been designated a Strategic Project by the European Union, enhancing its development prospects. Meanwhile, Evion’s joint venture in India secured a maiden US order for expandable graphite, signaling growing global demand.

Albion Resources has agreed to sell its Mongers Lake Project to Capricorn Metals for an upfront A$1.5 million, with additional milestone payments tied to resource and mining developments. This deal allows Albion to sharpen its focus on its high-grade Yandal West Gold Project.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

Estrella Resources has made significant strides in its maiden manganese drilling campaign in Timor-Leste, confirming high-grade mineralisation and advancing a major limestone marketing agreement with an Indonesian partner.

Juno Minerals has agreed to sell its Mount Mason DSO Hematite Project for A$6 million cash plus a 2% royalty, while maintaining focus on its flagship Mount Ida Magnetite Project. The transaction strengthens Juno’s cash position and sets the stage for renewed development efforts.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.

Yugo Metals Limited progresses its Petrovo exploration project amid promising historical drill results, completing a $0.4 million placement and announcing key board changes.